by Benzinga Insights | Mar 12, 2026 | General
Ciena (NYSE:CIEN) has outperformed the market over the past 5 years by 31.58% on an annualized basis producing an average annual return of 42.54%. Currently, Ciena has a market capitalization of $47.48 billion. Buying $100 In CIEN: If an investor had bought $100 of...
by Benzinga Insights | Mar 12, 2026 | General
Global X Artificial Intelligence & Technology ETF (NASDAQ:AIQ) has outperformed the market over the past 10 years by 8.78% on an annualized basis producing an average annual return of 21.38%. Currently, Global X Artificial Intelligence & Technology ETF has a...
by Benzinga Insights | Mar 12, 2026 | General
Oracle (NYSE:ORCL) has outperformed the market over the past 20 years by 4.55% on an annualized basis producing an average annual return of 13.08%. Currently, Oracle has a market capitalization of $456.12 billion. Buying $100 In ORCL: If an investor had bought $100 of...
by Benzinga Insights | Mar 12, 2026 | General
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 4.98% on an annualized basis producing an average annual return of 13.51%. Currently, Vertex Pharmaceuticals has a market capitalization of $121.71 billion. Buying $1000 In...
by Adam Eckert | Mar 12, 2026 | General
Eastman Kodak Co (NYSE:KODK) shares are soaring in Thursday’s after-hours session on the heels of the company’s fourth-quarter results. Here’s what you need to know. Eastman Kodak stock is among today’s top performers. What’s driving KODK stock higher? Kodak Reports...
Recent Comments